Abstract
Infections of the kidney and urinary tract are a common cause of morbidity, and sometimes mortality, especially in young women. The responsible pathogens include bacteria, viruses, protozoa, parasites, and fungi. The clinical nature of the infection can be different in the immunosuppressed, in the setting of kidney transplantation, and in other conditions, including vasculitis, glomerulopathy and cancer. Some infections can lead to systemic immune activation, which can in turn lead to kidney disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Ndulue C, Jisike-Onuigbo N, Anyanor A, Ozuemba B, Osakwe A, Oguejiofor N, et al. SAT-459 purple urine bag syndrome in a Nigerian with gastrointestinal bleeding. Kidney Int Rep. 2020;5(3):S191–2.
Godaly G, Ambite I, Svanborg C. Innate immunity and genetic determinants of urinary tract infection susceptibility. Curr Opin Infect Dis. 2015;28:88–96.
Medina M, Castillo-Pino E. An introduction to the epidemiology and burden of urinary tract infections. Ther Adv Urol. 2019;11:3–7.
Tan CW, Chlebicki MP. Urinary tract infections in adults. Singap Med J. 2016;57(9):485–90.
Tandogdu Z, Wagenlehner FM. Global epidemiology of urinary tract infections. Curr Opin Infect Dis. 2016;29:73–9.
NICE Guideline: urinary tract infection (lower): antimicrobial prescribing. www.nice.org.uk/guidance/ng109. Accessed 20 Apr 2020.
EAU Guidelines. Edn. Presented at the EAU annual congress Barcelona 2019. isbn:978-94-92671-04-2.
Smelov V, Naber K, Bjerklund Johansen KE. Improved classification of urinary tract infection: future considerations. Eur Urol Suppl. 2016;5:71–80.
Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103–20.
Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis. 1992;15(suppl 1):S216–27.
Anger J, Lee U, Ackerman AL, Chou R, Chughtai B, Clemens JQ, et al. Recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU guideline. J Urol. 2019;202:282–9.
NICE Guidance—Complicated urinary tract infections: ceftolozane/tazobactam. BJU Int. 2018;121:825–834.
NICE guideline: urinary tract infection (recurrent): antimicrobial prescribing. www.nice.org.uk/guidance/ng112. Accessed 20 Apr 2020.
Kulchavenya E. Best practice in the diagnosis and management of urogenital tuberculosis. Ther Adv Urol. 2013;5:143–51.
Pang Y, Shang Y, Lu J, Liang Q, Dong L, Li Y, et al. GeneXpert MTB/RIF assay in the diagnosis of urinary tuberculosis from urine specimens. Sci Rep. 2017;7:6181. https://doi.org/10.1038/s41598-017-06517-0.
Cek M, Lenk S, Naber KG, Bishop MC, Johansen TEB, Botto H, et al. EAU guidelines for the management of genitourinary tuberculosis. Eur Urol. 2005;48:353–62.
Yang C-W. Leptospirosis renal disease: emerging culprit of chronic kidney disease unknown etiology. Nephron. 2018;138:129–36.
Qiang XH, Yu TO, Li YN, Zhou LX. Prognosis risk of urosepsis in critical care medicine: a prospective observational study. Biomed Res Int. 2016;2016:9028924, 5 pages. https://doi.org/10.1155/2016/9028924.
Neild GH, Thomson G, Nitsch D, et al. Renal outcome in adults with renal insufficiency and irregular asymmetrical kidneys. BMC Nephrol. 2004;5:12.
Global tuberculosis report 2021. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.
World Health Organization. Global tuberculosis report 2019. https://www.who.int/tb/publications/global_report/en/. Accessed 20 Apr 2020.
Gonzalez OY, Teeter LD, Thanh BT, Musser JM, Graviss EA. Extrathoracic tuberculosis lymphadenitis in adult HIV seronegative patients: a population-based analysis in Houston, Texas, USA. Int J Tuberc Lung Dis. 2003;7:987–93.
Daher EF, Silva Junior GB, Guardao Barros EJ. Review: renal tuberculosis in the modern era. Am J Trop Med Hyg. 2013;88(1):54–64.
Mallinson WJW, Fuller RW, Levison DA, et al. Diffuse interstitial renal tuberculosis. An unusual cause of renal failure. QJM. 1981;198:137–48.
Oliveira B, Jayawardene S, Shah S. Single centre experience of granulomatous interstitial nephropathy; time for a new approach? Clin Kidney J. 2017;10:249–54.
Eastwood JB, Zaidi M, Maxwell JD, et al. Tuberculosis as primary renal diagnosis in end-stage uremia. J Nephrol. 1994;7:290–3.
Global leprosy update, 2016: accelerating reduction of disease burden. WHO Weekly Epidemiological Record. 2017;92(35):501–520.
Nakayama EE, Ura S, Fleury RN, Soares V. Renal lesions in leprosy: a retrospective study of 199 autopsies. Am J Kidney Dis. 2001;38(1):26–30.
Silva Junior GB, Daher EF, Pires Neto RJ, et al. Leprosy nephropathy: a review of clinical and histopathological features. Rev Inst Med Trop Sao Paulo. 2015;57:15–20.
Torgerson PR, Hagan JE, Costa F, Calcagno J, Kane M, Martinez-Silveira MS, et al. Global burden of leptospirosis: estimated in terms of disability adjusted life years. PLoS Negl Trop Dis. 2015;9:e0004122.
Herath NJ, Kularatne SA, Weerakoon KG, Wazil A, Subasinghe N, Ratnatunga NV. Long term outcome of acute kidney injury due to leptospirosis? A longitudinal study in Sri Lanka. BMC Res Notes. 2014;7:398.
Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl. 2012;2:139–274.
Prasad N, Patel MR. Infection-induced kidney diseases. Front Med. 2018;5:327. https://doi.org/10.3389/fmed.2018.00327.
Schiffl H. Renal recovery from acute tubular necrosis requiring renal replacement therapy: a prospective study in critically ill patients. Nephrol Dial Transplant. 2006;21:1248–52. https://doi.org/10.1093/ndt/gfk069.
Lopes JA, Jorge S, Resina C, Santos C, Pereira A, Neves J, et al. Acute kidney injury in patients with sepsis: a contemporary analysis. Int J Infect Dis. 2009;13:176–81.
Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41:1411–23.
Naughton CA. Drug-induced nephrotoxicity. Am Fam Physician. 2008;78(6):743–50.
Awdishu L, Mehta RL. The 6R’s of drug induced nephrotoxicity. BMC Nephrol. 2017;18:124. https://doi.org/10.1186/s12882-017-0536-3.
Lizarraga KJ, Nayer A. Dengue-associated kidney disease. J Nephropathol. 2014;3(2):57–62.
Nasim A, Anis S, Baqi S, Akhtar SF, Baig-Ansari N. Clinical presentation and outcome of dengue viral infection in live-related renal transplant recipients in Karachi, Pakistan. Transplant Infect Dis. 2013;5(15):516–25.
Jessie K, Fong MY, Devi S, Lam SK, Wong KT. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis. 2004;189(8):1411–8.
Méndez A, González G. [Dengue haemorrhagic fever in children: ten years of clinical experience]. Biomedica. 2003;23(2):180–193.
Jonsson CB, Figueiredo LTM, Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease. Clin Microbiol Rev. 2010;23(2):412–41.
Krautkrämer E, Grouls S, Stein N, Reiser J, Zeier M. Pathogenic old world hantaviruses infect renal glomerular and tubular cells and induce disassembling of cell-to-cell contacts. J Virol. 2011;85(19):9811–23.
Ferluga D, Vizjak A. Hantavirus nephropathy. JASN. 2008;19(9):1653–8.
Miettinen MH, Mäkelä SM, Ala-Houhala IO, Huhtala HSA, Kööbi T, Vaheri AI, et al. Ten-year prognosis of Puumala hantavirus-induced acute interstitial nephritis. Kidney Int. 2006;69(11):2043–8.
Gamage CD, Sarathkumara YD. Chronic kidney disease of uncertain etiology in Sri Lanka: are leptospirosis and Hantaviral infection likely causes? Med Hypotheses. 2016;91:16–9.
Prasad N, Novak JE, Patel MR. Kidney diseases associated with parvovirus B19, Hanta, Ebola, and dengue virus infection: a brief review. Adv Chronic Kidney Dis. 2019;26(3):207–19.
Baseler L, Chertow DS, Johnson KM, Feldmann H, Morens DM. The pathogenesis of Ebola virus disease. Annu Rev Pathol. 2017;12:387–418.
Uyeki TM, Mehta AK, Davey RT, Liddell AM, Wolf T, Vetter P, et al. Clinical management of Ebola virus disease in the United States and Europe. N Engl J Med. 2016;374(7):636–46.
Zolnourian ZR, Curran MD, Rima BK, Coyle PV, O’Neill HJ, Middleton D. Parvovirus B19 in kidney transplant patients. Transplantation. 2000;69(10):2198–202.
Waldman M, Kopp JB. Parvovirus B19 and the kidney. Clin J Am Soc Nephrol. 2007;2(Suppl 1):S47–56.
Wierenga KJ, Pattison JR, Brink N, Griffiths M, Miller M, Shah DJ, et al. Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease. Lancet. 1995;346(8973):475–6.
Leiri N, Hotta O, Taguma Y. Characteristics of acute glomerulonephritis associated with human parvovirus B19 infection. Clin Nephrol. 2005;64(4):249–57.
Liefeldt L, Buhl M, Schweickert B, Engelmann E, Sezer O, Laschinski P, et al. Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy. Nephrol Dial Transplant. 2002;17(10):1840–2.
Hirsch HH, Knowles W, Dickenmann M, Passweg J, Klimkait T, Mihatsch MJ, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med. 2002;347(7):488–96.
Randhawa PS, Finkelstein S, Scantlebury V, Shapiro R, Vivas C, Jordan M, et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation. 1999;67(1):103–9.
Hirsch HH, Brennan DC, Drachenberg CB, Ginevri F, Gordon J, Limaye AP, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation. 2005;79(10):1277–86.
Drachenberg CB, Beskow CO, Papadimitriou JC, Cangro CB, Rocca M, Klassen DK, et al. Human polyoma virus infected cells (PoVIC): incidence in renal biopsies (BX), urine cytology and correlation with clinical presentation. Transplantation. 1999;67(7):S217.
Hirsch HH. Human polyomavirus and papillomavirus infection and disease posttransplant. In: Transplant infections. Springer; 2016. p. 631–652.
Nankivell BJ, Renthawa J, Jeoffreys N, Kable K, O’Connell PJ, Chapman JR, et al. Clinical utility of urinary cytology to detect BK viral nephropathy. Transplantation. 2015;99(8):1715–22.
Drachenberg CB, Papadimitriou JC, Chaudhry MR, Ugarte R, Mavanur M, Thomas B, et al. Histological evolution of BK virus–associated nephropathy: importance of integrating clinical and pathological findings. Am J Transplant. 2017;17(8):2078–91.
Nickeleit V, Singh HK, Randhawa P, Drachenberg CB, Bhatnagar R, Bracamonte E, et al. The Banff working group classification of definitive polyomavirus nephropathy: morphologic definitions and clinical correlations. J Am Soc Nephrol. 2018;29(2):680–93.
Sawinski D, Goral S. BK virus infection: an update on diagnosis and treatment. Nephrol Dial Transplant. 2015;30(2):209–17.
Hirsch HH, Randhawa P, AST Infectious Diseases Community of Practice. BK polyomavirus in solid organ transplantation. Am J Transplant. 2013r;13(Suppl 4):179–88.
Cummins NW, Sohail MR. Cytomegalovirus, BK, and other viral infections of the kidney. In: Core concepts in parenchymal kidney disease. Springer; 2014. p. 229–240.
Helanterä I, Koskinen P, Finne P, Loginov R, Kyllönen L, Salmela K, et al. Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survival. Transpl Int. 2006;19(11):893–900.
Agrawal V, Gupta RK, Jain M, Prasad N, Sharma RK. Polyomavirus nephropathy and cytomegalovirus nephritis in renal allograft recipients. Indian J Pathol Microbiol. 2010;53(4):672–5.
Posadas Salas MA, Thompson J, Kadian M, Ngo T, Bruner E, Self S. Cytomegalovirus renal infection: rare manifestation of a common post-transplant viral infection-a case series. Transpl Infect Dis. 2019;21(6):e13169.
Fogo A. Cytomegalovirus infection. Am J Kidney Dis. 2000;36(2):E7–8.
Ferreira AC, Navarro D. Cytomegalovirus nephropathy in the transplant patient. Nephrol Dial Transplant. 2021;36:777–8. https://doi.org/10.1093/ndt/gfz194.
Kole AK, Roy R, Kole DC. An observational study of complications in chickenpox with special reference to unusual complications in an apex infectious disease hospital, Kolkata, India. J Postgrad Med. 2013;59(2):93–7.
Os I, Ström EH, Stenehjem A, Gudmundsdottir H, Langberg H, Draganov B, et al. Varicella infection in a renal transplant recipient associated with abdominal pain, hepatitis, and glomerulonephritis. Scand J Urol Nephrol. 2001;35(4):330–3.
Zaki S, Bhongade S, Shanbag P. Acute glomerulonephritis following varicella infection. Indian J Nephrol. 2012;22(1):64. https://doi.org/10.4103/0971-4065.83753.
Condom P, Mansuy J-M, Decramer S, Izopet J, Mengelle C. Atypical hemolytic uremic syndrome triggered by varicella infection. ID Cases. 2017;9:89–90.
Bazerbachi F, Haffar S, Garg SK, Lake JR. Extra-hepatic manifestations associated with hepatitis E virus infection: a comprehensive review of the literature. Gastroenterol Rep (Oxf). 2016;4(1):1–15.
Pischke S, Hartl J, Pas SD, Lohse AW, Jacobs BC, Van der Eijk AA. Hepatitis E virus: infection beyond the liver? J Hepatol. 2017;66(5):1082–95.
Agrawal P, Kumar V, Kumar A, Sachdeva MUS, Malhotra P, Nada R. Monoclonal Gammopathy of renal significance triggered by viral E hepatitis. Indian J Nephrol. 2019;29(1):50–2.
Kamar N, Rostaing L, Izopet J. Hepatitis E virus infection in immunosuppressed patients: natural history and therapy. In: Seminars in liver disease. New York: Thieme Medical Publishers; 2013. p. 62–70.
Andrievskaya M, Lenhart A, Uduman J. Emerging threat: changing epidemiology of hepatitis A and acute kidney injury. Adv Chronic Kidney Dis. 2019;26(3):171–8.
Fan P-C, Chen Y-C, Tian Y-C, Chang C-H, Fang J-T, Yang C-W. Acute renal failure associated with acute non-fulminant hepatitis A: a case report and review of literature. Ren Fail. 2009;31(8):756–64.
Bhimma R, Coovadia HM. Hepatitis B virus-associated nephropathy. Am J Nephrol. 2004;24(2):198–211.
Kamimura H, Setsu T, Kimura N, Yokoo T, Sakamaki A, Kamimura K, et al. Renal impairment in chronic hepatitis B: a review. Diseases. 2018;6(2):52. https://doi.org/10.3390/diseases6020052.
Li D, Gao G, Jiang H, Tang Z, Yu Y, Zang G. Hepatitis B virus-associated glomerulonephritis in HBsAg serological-negative patients. Eur J Gastroenterol Hepatol. 2015;27(1):65–9.
Lai K. Hepatitis-related renal disease. Futur Virol. 2011;6:1361–76.
Pipili C, Papatheodoridis G, Cholongitas E. Treatment of hepatitis B in patients with chronic kidney disease. Kidney Int. 2013;84:880–5.
Gill K, Ghazinian H, Manch R, Gish R. Hepatitis C virus as a systemic disease: reaching beyond the liver. Hepatol Int. 2016;3(10):415–23.
Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH. Hepatitis C and renal disease: an update 1. Am J Kidney Dis. 2003;42(4):631–57.
Kidney Disease: Improving Global Outcomes HCV Work Group. KDIGO 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int Suppl. 2018;8(3):91–165.
Jotwani V, Atta MG, Estrella MM. Kidney disease in HIV: moving beyond HIV-associated nephropathy. JASN. 2017;28(11):3142–54.
Swanepoel CR, Atta MG, D’Agati VD, Estrella MM, Fogo AB, Naicker S, et al. Kidney disease in the setting of HIV infection: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2018;93(3):545–59.
Fabian J, Naicker S. HIV and kidney disease in sub-Saharan Africa. Nat Rev Nephrol. 2009;5(10):591–8. https://doi.org/10.1038/nrneph.2009.141.
Kasembeli AN, Duarte R, Ramsay M, Mosiane P, Dickens C, Dix-Peek T, et al. APOL1 risk variants are strongly associated with HIV-associated nephropathy in black South Africans. JASN. 2015;26(11):2882–90.
Dummer PD, Limou S, Rosenberg AZ, Heymann J, Nelson G, Winkler CA, et al. APOL1 kidney disease risk variants: an evolving landscape. Semin Nephrol. 2015;35(3):222–36.
Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, et al. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol. 2011;22(11):2129–37.
Nobakht E, Cohen SD, Rosenberg AZ, Kimmel PL. HIV-associated immune complex kidney disease. Nat Rev Nephrol. 2016;12(5):291–300.
Cheng Y, Luo R, Wang K, et al. Kidney disease is associated with in-hospital death of COVID-19 patients. Kidney Int. 2020;97:829–38. https://doi.org/10.1016/kint.2020.03.005.
Chen YT, Shao SC, Hsu CK, et al. Incidence of acute kidney injury in COVID-19 infection: a systematic review and metanalysis. Crit Care. 2020;24:346. https://doi.org/10.1186/s13054-020-03009-y.
Ali H, Daoud A, Mohamed MM, Salim SA, Yessayan L, Baharani J, et al. Survival rate in acute kidney injury superimposed COVID-19 patients: a systematic review and meta-analysis. Ren Fail. 2020;42:393–7. https://doi.org/10.1080/0886022x2020.17.
Batlle D, Soler MJ, Sparks MA, Hiremath S, South AM, Welling PA, et al., on behalf of the COVID-19 and ACE2 in Cardiovascular, Lung, and Kidney Working Group. Acute kidney injury in COVID-19: emerging evidence of a distinct pathophysiology. JASN. 2020;31:1380–1383. https://doi.org/10.1681/ASN.2020040419.
Kudose S, Batal I, Santoriello D, Xu K, Barasch J, Peleg Y, et al. Kidney biopsy findings in patients with COVID-19. JASN. 2020;31(9):2158–67. https://doi.org/10.1681/ASN.2020050744.
Fisher M, Yunes M, Mokrzycki MH, et al. Chronic hemodialysis patients hospitalized with COVID-19—short-term outcomes in Bronx, New York. Kidney360. 2020;1(8):755–62. https://doi.org/10.34067/KID.0003672020.
Akalin E, Azzi Y, Bartash R, et al. Covid-19 and kidney transplantation. N Engl J Med. 2020;382:2475–7. https://doi.org/10.1056/NEJMc2011117.
https://www.who.int/malaria/en/. Accessed 30 Apr 2020.
World malaria report 2021. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.
Global distribution of Malaria in 2018—CDC ‘Heat’ Map. https://www.cdc.gov/malaria/travellers/country_table/a.html
Barsoum RS. Malarial acute renal failure. J Am Soc Nephrol. 2000;11:2147–54.
Das BS. Renal failure in malaria. J Vector Borne Dis. 2008;45:83–97.
Manan JA, Ali H, Lal M. Acute renal failure associated with malaria. J Ayub Med Coll Abbottabad. 2006;4:47–52.
Barsoum RS. Malarial nephropathies. Nephrol Dial Transplant. 1998;13:1588–97.
Kute VB, Trivedi HL, Vanikar AV, Shah PR, Gumber MR, Patel HV, et al. Plasmodium vivax malaria–associated acute kidney injury, India, 2010–2011. Emerg Infect Dis. 2012;18:842–5.
Naqvi R. Plasmodium vivax causing acute kidney injury: a foe less addressed. Pak J Med Sci. 2015;31:1472–5.
Bircan Z, Kervancioglu M, Soran M, Gonlusen G, Tuncer I. Two cases of nephrotic syndrome and tertian malaria in South-Eastern Anatolia. Pediatr Nephrol. 1997;11(1):78–9.
da Silva Junior GB, Pinto JR, Barros EJG, Geysa Farias GMN, De Francesco DE. Kidney involvement in malaria: an update. Rev Inst Med Trop São Paulo. 2017;59:e53. https://doi.org/10.1590/S1678-9946201759053.
Poti KE, Sullivan DJ, Dondorp AM, Woodrow CJ. HRP2: transforming malaria diagnosis, but with caveats. Trends Parasitol. 2020;36(2):112–26. https://doi.org/10.1016/j.pt.2019.12.004.
Plucinski MM, Candrinho B, Dimene M, Colborn J, Lu A, Nace D, et al. Assessing performance of HRP2 antigen detection for malaria diagnosis in Mozambique. J Clin Microbiol. 2019;57(9):e00875–919. https://doi.org/10.1128/JCM.00875-19.
WHO Malaria Publications. Management of severe malaria. In: A practical handbook. 3rd ed. 2012. isbn:978-92-4-154852-6. https://www.who.int/malaria/publications/atoz/9789241548526/en/
Ismail SA, Kamal W, Salem HK. Schistosoma prevalence world-wide. In: Schistosomiasis. 2016. isbn:978-1-944685-64-5. http://www.smgebooks.com/schistosomiasis/index.php#
World Health Organization. https://www.who.int/schistosomiasis/epidemiology/table3/en/. Accessed 2 May 2020.
CDC. www.cdc.gov/parasites/schistosomiasis. Accessed 2 May 2020.
da Silva Junior GB, Duarte DB, Barros EJ, De Francesco DE. Schistosomiasis-associated kidney disease: a review. Asian Pac J Trop Dis. 2013;3(1):79–84.
Barsoum RS. Schistosomal glomerulopathies. Kidney Int. 1993;44:1–12.
Seck SM, Sarr ML, Dial MC, Ka EF. Schistosoma hematobium-associated glomerulopathy. Indian J Nephrol. 2011;21(3):201–3. https://doi.org/10.4103/0971-4065.78076.
Barsoum RS, Esmat G, El-Baz T. Human schistosomiasis: clinical perspective. J Adv Res. 2013;4(5):433–44.
Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis. 1992;15:414–21. https://doi.org/10.1093/clind/15.3.414.
Singh N. Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices. Clin Infect Dis. 2001;33:1692–6. https://doi.org/10.1086/323895.
Badiee P, Hashemizadeh Z. Opportunistic invasive fungal infections: diagnosis & clinical management. Indian J Med Res. 2014;139:195.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Questions
Questions
-
1.
A 55 year old man presented to the emergency room with fever, non-productive cough, anosmia, muscle aches and fatigue for one day and sore throat for 3 days. He had been to his local pub 5 days previously. His temperature was 38.3 °C, BP 124/76, respiratory rate 28/min and oxygen saturation 88%. Chest radiograph was suggestive of bilateral lower lobe interstitial pneumonitis. Laboratory results revealed haemoglobin 13.3 g/dL; white cell count 4.1 × 109/L; lymphocyte count 1.3 × 109/L; blood glucose 12.2 mmol/L; serum creatinine 98 μmol/L; CRP 185 mg/L. Three days after admission he was breathless and transferred to ITU, his creatinine increased to 210 μmol/L.
What is the most likely cause of his illness?
-
A.
COVID-19
-
B.
Cytomegalovirus infection
-
C.
Staphylococcus infection
-
D.
Pneumococcus infection
-
E.
Malaria
Answer: A
A nasal swab PCR confirmed the diagnosis of COVID-19. He was admitted to the intensive care unit and commenced on intravenous fluids, high flow oxygen via a nasal cannula, enoxaparin 20 mg subcutaneously, dexamethasone 6 mg daily intravenously and insulin adjusted according to glucometer readings. He was transferred out of ICU after 5 days and continued to improve in hospital.
-
A.
-
2.
A 30 year old black woman, recipient of a deceased donor kidney transplant 3 months previously, was noted to have a decline in her baseline kidney function at a clinic visit. She had received antithymocyte globulin, high dose steroid induction therapy and was being maintained on tacrolimus, mycophenolate mofetil (MMF) and prednisolone. She had been noted to be CMV IgG positive while on dialysis. Her BP was130/60 mmHg, pulse 78/min and temperature 39 °C. Laboratory tests: haemoglobin 11.8 g/dL; WCC 3.1 × 109/L; platelet count 130,000; serum creatinine 180 μmol/L from a previous baseline of 110 μmol/L. Urine examination revealed 50 red cells/HPF and proteinuria of 0.5 g/day. Tacrolimus levels were between 5 and 15 ng/mL. She underwent a kidney biopsy.
Histology of the allograft biopsy showed a peritubular mononuclear interstitial infiltrate; some tubular cells had intranuclear inclusions.
What is the most likely diagnosis?
-
A.
Acute cellular rejection
-
B.
Acute antibody mediated rejection
-
C.
BK virus infection
-
D.
Cytomegalovirus infection
-
E.
Tacrolimus toxicity
Answer: D
CMV viral load was 15,000 copies/mL. She was treated with intravenous ganciclovir 5 mg/kg every 12 h for 14 days, and thereafter maintained on valganciclovir 900 mg daily for 30 days. MMF was discontinued, tacrolimus dose was optimized according to blood levels, and she continued with low dose prednisolone. Her serum creatinine stabilized at 125 μmol/L.
-
A.
-
3.
An 18-year old boy, recipient of a second (deceased donor) kidney transplant was noted to have an asymptomatic rise in his serum creatinine during a routine clinic visit 12 months after transplantation. He had received antithymocyte globulin, high dose steroid induction therapy and was being maintained on tacrolimus, mycophenolate mofetil (MMF) and prednisolone. He had been noted to be CMV IgG positive previously. He was noted to have haemoglobin 12.8 g/dL; WCC 5.1 × 109/L; platelet count 230,000; serum creatinine 220 μmol/L from a previous baseline of 120 μmol/L. Urine cytology showed epithelial cells with viral inclusions ‘decoy cells’, Allograft biopsy showed mononuclear interstitial inflammation, and some degree of tubulitis with basophilic changes of the tubular epithelium.
What is the most likely diagnosis?
-
A.
Acute cellular rejection
-
B.
Acute antibody mediated rejection
-
C.
BK virus infection
-
D.
Cytomegalovirus infection
-
E.
Tacrolimus toxicity
Answer: C
He had a urine BK load of 117 copies/mL and a serum BK viral load of 105 copies/mL. His MMF dose was halved, and tacrolimus trough levels lowered and he was treated with leflunomide 100 mg daily for 5 days and 40 mg daily thereafter until the virus was cleared. His kidney function gradually stabilized to around his baseline levels and surveillance for BKV is carried out on a monthly basis.
-
A.
-
4.
A 45 year old black man was recently diagnosed with HIV infection and referred to a Renal Clinic with proteinuria and renal dysfunction. He had minimal ankle oedema, BP 126/82 and had 3 g proteinuria/day. His serum albumin was 25 g/L, serum cholesterol 4.1 mmol/L, serum creatinine 188 μmol/L, eGFR 42.1 mL/min/1.73 m2, CD4 count 180 cells/mL, viral load 125,000 copies/mL. He underwent a kidney biopsy.
What is the most likely biopsy diagnosis?
-
A.
Crescentic glomerulonephritis
-
B.
Focal segmental glomerulonephritis
-
C.
Membranous glomerulonephritis
-
D.
Membranoproliferative glomerulonephritis
-
E.
Minimal change disease
Answer: B
His kidney biopsy showed typical HIV associated nephropathy, with glomerular collapse, microcystic tubular dilatation and interstitial inflammation. He was commenced on Losartan 50 mg daily, and Abacavir 300 mg BD, Lamuvidine (3TC) 150 mg daily and Dolutegravir 50 mg daily. Avoid fixed dose combinations if GFR < 50 mL/min, and tenofovir if possible. His APOL1 genotype was not available.
-
A.
-
5.
A 25 year old man was admitted to the emergency room with a fever of 39.1 °C, and dehydration. He had been on a beach vacation in Mozambique 2 weeks previously. He was noted to have tachycardia of 100/min, BP 96/60 and was pale and had a 2 cm splenomegaly. His haemoglobin was 10.1 g/dL; white cell count 4.1 × 109/L; platelets 92,000; serum bilirubin 35 mmol/L; blood urea 32 mmol/L; serum creatinine 220 μmol/L.
What is the most likely cause of his acute kidney injury?
-
A.
Cytomegalovirus infection
-
B.
Epstein barr virus infection
-
C.
Malaria
-
D.
Pneumococcal infection
-
E.
Staphylococcus infection
Answer: C
A thin smear revealed the presence of tropozoites of P falciparum. He was commenced on intravenous fluids and therapy with artesunate 2.4 mg/kg intravenously immediately and 12 hourly for 24 h and thereafter switched to oral treatment with artemether-lumefantrine for 3 days. A blood smear at 72 h demonstrated that the parasitaemia had been eradicated and he made a a full recovery.
-
A.
-
6.
A 45 year old man, a visitor from Egypt, was hospitalized with abdominal distension. He had been an agricultural worker. He was noted to have hepatosplenomegly. Investigations showed dipstick proteinuria of 3+, and was measured to be 2.9 g/24 h; serum albumin 35 g/L; serum globulins 50 g/L; haemoglobin was 10.8 g/dL; white cell count 4.1 × 109/L; platelets 112,000; serum bilirubin 10 mmol/L; blood urea 5 mmol/L; serum creatinine 88 μmol/L. Ultrasound of the liver was suggestive of hepatic fibrosis, and was confirmed by fibroscan. A kidney biopsy showed membranoproliferative glomerulonephritis.
What is the cause of the renal disease?
-
A.
Cytomegalovirus infection
-
B.
Hepatitis B infection
-
C.
HIV infection
-
D.
Malaria
-
E.
Schistosomiasis
Answer: E
A stool specimen showed the presence of schistosoma mansoni. He was treated with praziquantel and advised to avoid future schistosomal infection, and to return to his physician for review.
-
A.
-
7.
A 25 year old forest worker in the Democratic Republic of the Congo presented to the Emergency Department with 3 day history of headache, fever, shivering at night, muscle ache and joint pains. The headache was worst behind the eyes and he also mentioned shivering at night. His temperature was 40.0 °C with a BP of 100/60 and regular tachycardia of 120/min. By Day 4 he had developed a maculo-papular rash with patches of purpura. Haemoglobin 13.0 g/dL, WBC 4.0 × 109/L, platelets 80 × 109/L [normal: 150–400]. Creatinine 350 μmol/L with urea 40 mmol/L, eGFR 24 mL/min/1.73 m2. There was proteinuria 0.6 g/L and RBC 50–100/μL. Renal biopsy was not considered as it was felt that it would not influence treatment; furthermore it would add an unnecessary hazard for someone already at risk of bleeding.
What is the most likely diagnosis?
-
A.
COVID 19 infection
-
B.
Dengue fever
-
C.
Ebola virus infection
-
D.
Malaria
-
E.
Tuberculosis infection
Answer: B
He was diagnosed with Dengue fever and managed with supportive treatment and scrupulous attention to clinical signs, pulse, blood pressure and urine output replacing fluid as necessary but avoiding overload. There is unfortunately no specific treatment for dengue virus and as yet no vaccine.
-
A.
-
8.
An 18 year-old female presented with history of fever for 2 weeks, and the passage of brown urine for 6 days, generalized body swelling for 5 days followed by reduced urine output and breathlessness for 2 days. She had a seizure episode a few hours before presentation. She had noted skin infections 3 weeks preceding the above symptoms. On presentation, she had impaired consciousness (GCS 8/15) but recovered within a few hours. She was pale, with bilateral pitting leg oedema temperature of 37.8 °C, respiratory rate 38 breaths/min, pulse 110 bpm and BP 160/110 mmHg. Urinalysis showed blood, protein, and microscopy revealed red cell casts. Her blood tests showed sodium: 122 mmol/L, potassium: 5.6 mmol/L, HCO3: 12.4 mmol/L, chloride: 84.4, iCa: 1.01, BUN: 63.3 mmol/L, creatinine: 884 μmol/L, haemoglobin: 8.3 g/dL, leukocytosis with neutrophila of 78%.
What is the most likeley investigation which will help with diagnosis?
-
A.
ASO titre
-
B.
ANCA
-
C.
Hepatitis B serology
-
D.
Kidney biopsy
-
E.
Serum immunoglobulin
Answer: A
Her ESR was 125 mm/hr and qualitative ASO titre: elevated/positive
-
A.
-
9.
An 18 year-old female presented with history of fever for 2 weeks, red-brown coloured urine for 6 days, generalized body swelling for 5 days followed by reduced urine output and breathlessness for 2 days. She had a seizure episode a few hours before presentation. She had noted skin infections 3 weeks preceding the above symptoms. On presentation, she had impaired consciousness (GCS 8/15) but recovered within a few hours. She was pale, with bilateral pitting leg oedema temperature of 37.8 °C, respiratory rate 38 breaths/min, pulse 110 bpm and BP 160/110 mmHg. Urinalysis showed blood, protein, and microscopy revealed red cell casts. Her blood tests showed sodium: 122 mmol/L, potassium: 5.6 mmol/L, HCO3: 12.4 mmol/L, chloride: 84.4, iCa: 1.01, BUN: 63.3 mmol/L, creatinine: 884 μmol/L, haemoglobin: 8.3 g/dL, leukocytosis with neutrophila of 78%.
What is the most likely diagnosis?
-
A.
Haemolytic uraemic syndrome
-
B.
IgA nephritis
-
C.
Lupus nephritis
-
D.
Post infectious glomerulonephritis
-
E.
Polyarteritis nodosa
Answer: D
Her ESR was 125 mm/hr and qualitative ASO titre: elevated/positive
-
A.
-
10.
A 42 year old rural drainage engineer, living in Sao Paulo state in southern Brazil, presented to the Dermatology clinic giving a history of intermittent skin rash sometimes associated with a change in pigmentation. He was found to have heavy proteinuria and referred to the nephrologist. In recent months he had been feeling more tired than usual. He had a pale complexion. There was mild oedema of the ankles. Temperature: 36.5 °C, Haemoglobin 100 g/L, sodium 140 mmol/L, Potassium 5.3 mmol/L, bicarbonate 22 mmol/L, creatinine 216 μmol/L, albumin 23 g/L. Urine protein amounted to 10.5 g/24 h. An MSU revealed neither cells nor blood or glucose; the urine was sterile on culture. A repeat of the investigations a week later gave similar results.
What is the most likely diagnosis?
-
A.
Leptospirosis
-
B.
Systemic lupus erythematosus
-
C.
Nephropathy of tuberculoid leprosy
-
D.
Amyloidosis secondary to lepromatous leprosy
-
E.
Falciparum malaria
Answer: D Amyloidosis secondary to lepromatous leprosy
-
A.
A. Leptospirosis | Incorrect | Lack of fever, and no active urinary sediment |
B. Systemic lupus erythematosus | Incorrect | No joint pain, no fever, no significant urinary sediment |
C. Nephropathy of tuberculoid leprosy | Incorrect | Nephrotic syndrome not common in the tuberculoid form of leprosy |
D. Amyloidosis secondary to lepromatous leprosy with nephrotic syndrome | Correct | Frequency of amyloidosis in leprosy types: lepromatous [36%], tuberculoid and borderline [5%]. The nephrotic syndrome is a consequence of the amyloidosis. |
E. Falciparum malaria | Incorrect | No fever or other evidence of malaria |
Test your learning and check your understanding of this book’s contents: use the “Springer Nature Flashcards” app to access questions using https://sn.pub/cz9Cok. To use the app, please follow the instructions in Chap. 1.
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Naicker, S., Eastwood, J.B., Ashuntantang, G., Ulasi, I. (2023). Infections and the Kidney. In: Banerjee, D., Jha, V., Annear, N.M. (eds) Management of Kidney Diseases. Springer, Cham. https://doi.org/10.1007/978-3-031-09131-5_14
Download citation
DOI: https://doi.org/10.1007/978-3-031-09131-5_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-09130-8
Online ISBN: 978-3-031-09131-5
eBook Packages: MedicineMedicine (R0)